Search and Filter
Results per Page:
Umbilical cord blood transplant with pooled stem cell product shows 96% survival and no graft-versus-host-disease in leukemia patients
A phase 2 study published in the Journal of Clinical Oncology shows that a stem cell product called dilanubicel safely enabled umbilical cord blood transplants in 28 patients
Registration for Obliteride 2026 now open
Annual bike ride and 5K set for Aug. 8, early registration discounted 50% for a limited time
Fred Hutch announces 12 recipients of the annual Harold M. Weintraub Graduate Student Award
Award recognizes innovative research by graduate students in biological sciences
Sabah Öney joins Fred Hutch Board of Directors
President and chief executive officer of Dispatch Bio brings expertise in biotechnology leadership and innovation
HIV/AIDS research has saved millions of lives globally and led to innovative advances in multiple diseases
Numerous medical advances originate from U.S.-funded HIV research
Experts urge clinical trials network to study infectious disease therapies in immunocompromised patients
More than 6% of Americans are immunocompromised, yet most clinical trials exclude them